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Naturally occurring 3RS, 7R, 11R-phytanic
acid suppresses in vitro T-cell production of
interferon-gamma
Tomonori Nakanishi1, Ibuki Motoba1, Mayuko Anraku1, Ryoji Suzuki1, Yuto Yamaguchi2, Laurie Erickson3,4,
Nozomu Eto1, Kazuhiro Sugamoto2, Yohichi Matsushita2 and Satoshi Kawahara1*
Abstract
Background: Among the eight stereoisomers of phytanic acid (PA), the 3RS, 7R, 11R-isomer is naturally occurring
and is present in foods and the human body. PA is considered to have possible health benefits in the immune
system. However, it remains undetermined whether these effects are elicited by the 3RS, 7R, 11R-PA isomer,
because previous studies used a commercially available PA whose isomer configuration is unknown. In this study,
we synthesized a preparation of 3RS, 7R, 11R-PA, and investigated its in vitro immunomodulatory effects, especially
the T-cell production of interferon (IFN)-γ, which is associated with various autoimmune diseases. This study also
investigated the effects of 3RS, 7R, 11R-PA on NF-κB activity in order to address the mechanism of its
immunomodulatory effects.
Methods: Mouse splenocytes and purified T-cells were stimulated with T-cell mitogens and incubated with 3RS, 7R,
11R-PA, followed by evaluation of IFN-γ production. The effect of 3RS, 7R, 11R-PA on NF-κB activity was also
investigated using an A549 cell line with stable expression of an NF-κB-dependent luciferase reporter gene.
Results: 3RS, 7R, 11R-PA significantly reduced in vitro IFN-γ production at both the protein and mRNA levels, and was
accompanied by decreased expression of T-bet, a key regulator of Th1 cell differentiation. The results indicated that NF-
κB-mediated transcriptional activity was significantly decreased by 3RS, 7R, 11R-PA and that GW6471, an antagonist of
peroxisome proliferator activated receptor α (PPARα), abrogated the inhibitory effect of 3RS, 7R, 11R-PA on NF-κB activity.
Conclusions: The present study suggests that 3RS, 7R, 11R-PA is a functional and bioactive fatty acid, and has a
potentially beneficial effect for amelioration of T-cell mediated autoimmune diseases. This study also indicates that
interference in the NF-κB pathway via PPARα activation is a potential mechanism of the immunomodulatory effects of
3RS, 7R, 11R-PA.
Keywords: 3RS, 7R, 11R-phytanic aid, T-cell, IFN-γ production, NF-κB activity, PPARα
Background
Phytanic acid (3, 7, 11, 15-tetramethyl-hexadecanoic acid,
PA) is a branched-chain fatty acid and originates from the
phytol side chain of chlorophyll. Some microorganisms
inhabiting the rumen of ruminants produce phytol from
chlorophyll, after which PA is formed via oxidation of
phytol to phytenic acid. Therefore, dairy products and
ruminant meat as well as some marine lipids are rich
sources of PA [1]. Because humans are not capable of pro-
ducing phytol from chlorophyll, PA in the human body is
exclusively derived from the above foods.
PA is a ligand for several subtypes of peroxisome pro-
liferator activated receptor (PPAR) [2, 3]. PPARs regulate
gene expression in cellular differentiation, development
and metabolism, and are attractive molecular targets for
human metabolic disease [4], type 2 diabetes [5] and
autoimmune diseases [6]. PA has been shown to stimu-
late glucose uptake in primary porcine myotubes, sug-
gesting a potential role of PA in the management of
insulin resistance [7]. Our previous studies addressing
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the immunomodulatory effects of PA have demonstrated
that PA inhibits T-cell production of cytokines, such as
interferon (IFN)-γ, which are associated with various
autoimmune diseases [8]. Based on these findings, PA is
now recognized as a food component with possible ben-
efits for human health, albeit the precise molecular
mechanism still remains unclear [9].
PA has three chiral centers at carbon positions 3, 7
and 11, which means that there are theoretically eight
stereoisomers. In nature, the methyl groups at 7 and 11
are in the R configuration because they are in
chlorophyll-derived phytol (2E, 7R, 11R-isomer). The
configuration at position 3 in PA can be R or S, and con-
sequently naturally occurring PA (nPA) is the diastereo-
meric mixture of 3R, 7R, 11R- and 3S, 7R, 11R-isomers
[10]. However, most previous studies have used com-
mercially available PA which is a mixture of natural and
non-natural isomers or whose isomer information is un-
known. Therefore, there are unanswered questions of
whether nPA can elicit the above beneficial effects. Be-
cause individual isomers of fatty acids differ widely in their
biological effects [11], evaluation of nPA is important to
determine the biochemical and physiological effects of PA.
Here, we synthesized a mixture containing equal
amounts of the 3R, 7R, 11R- and the 3S, 7R, 11R-isomers
in order to evaluate the in vitro immunomodulatory ef-
fects of nPA on IFN-γ production by T-cells, to address
the potential for prevention of autoimmune disease. We
also investigated the effects of nPA on NF-κB-mediated
transcriptional activity to elucidate the mechanism by
which nPA elicits the immunomodulatory effects.
Methods
Preparation of nPA from phytol
Phytol 95 containing 92% of phytol derived from chlorophyll
was purchased from Tama Biochemical CO., Ltd. (Tokyo,
Japan) and was purified by column chromatography on silica
gel with hexane−diethyl ether (2:1) as an eluent to give pure
phytol. Phytol was converted into nPA (Scheme 1).
Hydrogenation of phytol using Adams’ catalyst gave
3RS-phytanol according to Patton and Benson [12]. For con-
version of phytanol into PA, chromic acid oxidation under
acidic conditions has been almost exclusively used [12–14],
but the use of noxious chromic acid should be
avoided if possible. Therefore, we applied ruthenium
tetroxide-catalyzed oxidation with NaIO4 [15] instead
of the chromic acid oxidation.
Briefly, to a solution of phytol (5.05 g) in ethanol
(170 mL) was added 58.6 mg of Adams’ catalyst (PtO2).
After the atmosphere of reaction vessel had been re-
placed with hydrogen, the reaction mixture was stirred
at room temperature for 2.5 h under 1 atm of hydrogen.
The catalyst was removed from the mixture by filtering
through a celite pad. The filtrate was evaporated on a
rotary evaporator to 5.7 g of the crude product as a col-
orless oil. The crude product was purified by column
chromatography on silica gel (50 g) with hexane and
then hexane-ethyl acetate (20:1) as an eluent. Phytane
(1.27 g) produced by hydrogenolysis was obtained in
26.4% yield from hexane-eluted fraction, and 3RS-phyta-
nol (3.64 g) in 71.6% as a colorless oil from the fraction
eluted with hexane-ethyl acetate (20:1). The spectral data
for synthesized phytanol coincided with those reported
by Burns et al. [14].
3RS-phytanol (3.58 g) was dissolved in a mixed solvent
of acetonitrile (24 mL) and ethyl acetate (24 mL), and
water (36 mL) was added to this solution. To the
mixture were added sodium periodate (10.53 g) and
ruthenium chloride hydrate (62.2 mg) sequentially. The
reaction mixture was stirred at room temperature for
2 h. The reaction mixture was filtered to remove insol-
uble solids, and the organic layer was separated from the
two-layered filtrate. The aqueous layer was extracted
with ethyl acetate (2 × 60 mL). The combined organic
layers were dried over anhydrous sodium sulfate, evapo-
rated on a rotary evaporator, to afford 3.79 g of the
crude product as a brownish yellow oil. Purification of
the crude product on silica gel (70 g) with hexane−ethyl
Scheme 1 Conversion of phytol into naturally occurring phytanic acid (nPA)
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acetate−acetic acid (20:1:0.1) gave the desired nPA
(3.03 g) as a colorless oil in 88.2% yield. Its spectral data
coincided with those reported by Burns et al. [14].
In this study, nPA was used either as the form of free
fatty acids or as nPA-bovine serum albumin (BSA) con-
jugates. The conjugation of nPA with BSA was carried
out as previously described [16].
Animals and cells
Female C57BL/6 J mice aged 6 weeks were obtained
from Japan SLC, Inc. (Shizuoka, Japan). The spleens of
mice aged between 8 to 12 weeks were aseptically
collected and teased into single-cell suspensions. T-cells
were purified from mouse splenocytes by negative
immunomagnetic cell sorting (Pan T cell isolation kit II,
Miltenyi Biotec, Bergisch Gladbach, Germany). Mouse
splenocytes and purified T-cells were incubated in
RPMI-1640 medium containing 10% foetal calf serum,
100 units/mL penicillin and 100 μg/mL streptomycin.
Animals were used in accordance with the guidelines for
the care and use of laboratory animals at the University
of Miyazaki and Law No. 105 of the Japanese govern-
ment. All experimental protocols were approved by the
University of Miyazaki (approval number: 2014–002).
A549 human lung epithelial cells with stable expression
of an NF-κB-dependent luciferase reporter gene were
purchased from Panomics (RC0002, Freemont, CA,
USA). A549 cells were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% foetal calf
serum, 100 units/mL penicillin and 100 μg/mL strepto-
mycin. All cells were incubated at 37°C in a humidified
atmosphere of 5% CO2–95% air.
Cellular toxicity
For assessing the cellular toxicity of the test fatty acids,
3.0 × 105 mouse splenocytes or purified T-cells, or 5.0 × 103
A549 cells were independently incubated in flat-bottomed
microtiter 96-well plates, along with various concentration
of nPA dissolved in dimethyl sulfoxide (DMSO) and added
as a final DMSO concentration of 0.1%. The control fatty
acid was palmitic acid, whose carbon chain is the same
length as that of PA. Following incubation for 72 h, an
Alamar blue assay was performed according to the manu-
facturer’s instructions (Invitrogen, Gaithersburg, MD, USA).
Fluorescence was measured with excitation at 550 nm and
emission at 590 nm using a Varioskan Flash 2.4 (Thermo
Fisher Scientific Inc., Waltham, MA, USA).
IFN-γ secretion
The 1.5 × 105 mouse splenocytes were incubated as
described for the cellular toxicity assay. Cells were stimu-
lated with 10 μg/mL phytohaemagglutinin (PHA) for
T-cell activation, along with various concentrations of
nPA or the control palmitic acid. After incubation at 37 °C
for 72 h, culture supernatants were harvested, and IFN-γ
secretion was measured by ELISA using a commercially
available kit (Biolegend, Inc., San Diego, CA, USA). Simi-
lar experiments were conducted using purified T-cells
stimulated with 50 ng/mL phorbol 12-myristate
13-acetate (PMA) and 500 ng/mL ionomycin and 48 h
incubation.
Quantitative reverse-transcription polymerase chain
reaction (qRT-PCR) for IFN-γ and T-bet mRNA levels
The 2.0 × 106 mouse splenocytes were incubated in
flat-bottomed 24-well plates along with test substances,
and were stimulated with 10 μg/mL PHA. Following in-
cubation at 37 °C for 24 h, total RNA was extracted
from the stimulated splenocytes using TRIzol reagent
(Life Technologies, Inc., Grand Island, NY, USA). cDNA
was synthesized from 0.5 μg total RNA using ReverTra
Ace (Toyobo Co., Ltd., Osaka, Japan). qRT-PCR was
done in the AriaMx Realtime PCR system (Agilent
Technologies, Inc., Santa Clara, CA, USA) with a com-
mercially available kit (Brilliant III Ultra-Fast SYBR
Green QPCR Master Mix, Agilent Technologies, Inc.) as
per the manufacturer’s instructions. The expression
levels of IFN-γ, T-bet and the housekeeping gene
GAPDH were assessed using pre-designed primers for
each gene (MA025911, IFN-γ; MA114313, T-bet;
MA050371, GAPDH, Takara Bio Inc., Shiga, Japan). A
threshold was set in the linear part of the amplification
curve, and the number of cycles required to reach the
threshold was calculated for each gene. Melting curve
analysis was performed to confirm the purity of the
amplified bands. Normalization was done using GAPDH
mRNA as an internal control for IFN-γ and T-bet
mRNA. Similar experiments were conducted using
purified T-cells stimulated with PMA and ionomycin as
described above.
NF-κB reporter assay
A549 cells transfected with an NF-κB-dependent luciferase
reporter gene were seeded in flat-bottomed 24-well plates
at a concentration of 2.5 × 104 cells per well. Cells were
stimulated with 20 ng/mL tumor necrosis factor (TNF)-α
(Peprotech, Rocky Hill, NJ, USA), following 24 h
pre-incubation with test substances. Medium was removed
7 h after addition of TNF-α, and cells were lysed with
50 mM Tris-HCl buffer (pH 8.5) containing 1% Triton
X-100. The transcriptional activity of NF-κB was deter-
mined by mixing cell lysates with a luciferase substrate
(Steady-Glo Luciferase Assay system, Promega, Madison,
WI, USA) according to the manufacturer’s instructions.
Luminescence was measured using a Varioskan Flash 2.4
(Thermo Fisher Scientific Inc.). Similar experiments were
conducted in the presence of a PPARα antagonist GW6471
(1 μM; Cayman Chemicals, Ann Arbor, MI, USA).
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Statistical analysis
Experiments were independently repeated more than
three times to confirm reproducibility. Differences
between the DMSO control and the test fatty acids were
compared using a one-way analysis of variance followed
by the Dunnett Multiple Comparison test, or an
unpaired t-test. All statistical analyses were performed
using the GraphPad Prism version 6.0 (GraphPad
Software, San Diego, CA, USA.)
Results
IFN-γ production and T-bet expression of mouse
splenocytes
To examine the cellular toxicity of test fatty acids, the
viability of mouse splenocytes was evaluated after incu-
bation for 72 h. Our results showed that both nPA and
the control palmitic acid had no cellular toxicity in con-
centrations up to 100 μM (Fig. 1a). The effects of nPA
on in vitro IFN-γ secretion were evaluated after PHA
stimulation of mouse splenocytes. nPA reduced IFN-γ
secretion in a concentration-dependent manner with
near-complete inhibition at 30 μM (Fig. 1b). On the
other hand, palmitic acid had no obvious effect on
IFN-γ secretion. The inhibitory effects of nPA were also
observed at the transcriptional level where mRNA
expression of IFN-γ was significantly decreased by treat-
ment with nPA at concentrations higher than 10 μM
(Fig. 1c). We also examined the effects of nPA on mRNA
expression of the T-box transcription factor T-bet be-
cause IFN-γ plays a key role in differentiation of CD4
positive-T-cells to Th1 lineages and T-bet is an import-
ant determinant of Th1 cell differentiation. Our results
showed that T-bet mRNA expression was strongly
suppressed by 30 μM nPA (Fig. 1d). Given that free fatty
acids are bound to albumin in human plasma, we also
evaluated the immunomodulatory effect of the nPA-BSA
conjugate. The results indicated that nPA significantly
inhibited IFN-γ mRNA expression even in the form of
BSA conjugate (Fig. 1e). Although the inhibitory effect of
the nPA-BSA conjugate was slightly less potent than free
fatty acids, further studies were carried out using the free
form of nPA to simplify experimental procedures.
T-cell production of IFN-γ
Splenocytes are composed of variety of leucocytes in-
cluding T-cells, B-cells, macrophages and dendritic cells,
although T-cells are considered the predominant source
of IFN-γ production. Therefore, we investigated the
direct action of nPA on T-cells. The cellular toxicity of
nPA was first evaluated using freshly purified T-cells,
showing that nPA had no obvious cellular toxicity in
concentrations up to 100 μM (Fig. 2a). The effect of
30 μM nPA on in vitro IFN-γ production was evaluated
after PMA/ionomycin stimulation of purified T-cells.
Our results indicated that nPA significantly inhibited
PMA/ionomycin-induced IFN-γ mRNA expression
(Fig. 2b). The inhibitory effect of nPA on IFN-γ produc-
tion was also confirmed at the translational level by
evaluation of the time course of IFN-γ secretion after
PMA/ionomycin stimulation (Fig. 2c). These findings
clearly indicated that nPA elicited its immunomodula-
tory effects through modification of T-cell function.
NF-κB reporter assay
To address the potential mechanism for the immuno-
modulatory effects of nPA, an NF-κB-dependent lucifer-
ase reporter assay was employed. No toxicity toward
A549 cells was observed with 30 μM of either nPA or
the control palmitic acid (Fig. 3a), consistent with the re-
sults on mouse splenocytes and purified T-cells. The in
vitro effects of 30 μM nPA or palmitic acid on
NF-κB-driven transcriptional activity were investigated
using A549 cells with stable expression of an
NF-κB-luciferase reporter gene. Our results indicated
that the control palmitic acid increased rather than de-
creased NF-κB activity in the A549 cells (Fig. 3b). Con-
trary to palmitic acid, nPA significantly decreased NF-κB
activity (Fig. 3b). The in vitro inhibitory effects of nPA
on NF-κB activity were completely abrogated when
PPARα was blocked by GW6471 (Fig. 3c), suggesting
that PPARα-mediated NF-κB inhibition could be the
molecular mechanism for the immunomodulatory ef-
fects of nPA.
Discussion
Unlike straight chain fatty acids which are metabolized
by β-oxidation, the metabolism of branched-chain fatty
acids proceeds through α-oxidation in the human body.
Several reports indicated that the abnormal accumula-
tion of PA in plasma and lipid-containing tissues is one
of the clinical signs of adult Refsum disease which is a
neurocutaneous syndrome with impaired α-oxidation of
branched chain fatty acids [17]. Consequently, the major-
ity of previous studies on PA have focused on its potential
toxicity on neuronal cells and its pathogenic role in
Refsum disease [18, 19]. Indeed, the plasma concentration
of PA in patients with Refsum disease (> 200 μM) proved
to be higher than normal (< 30 μM) [17]. In this study, we
used a nPA mixture containing equal amounts of the 3R,
7R, 11R- and the 3S, 7R, 11R-isomers for in vitro studies
because these isomers are present in the human body.
Our results showed no obvious cellular toxicity in mouse
splenocytes (Fig. 1a) and purified T-cells (Fig. 2a) when
treated with a high dose of 100 μM nPA. Given these find-
ings, we decided to investigate the in vitro immunomodu-
latory effects of nPA at concentrations up to 30 μM,
corresponding to the plasma concentration of healthy
humans. This study is the first report of the ability of nPA
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to inhibit in vitro IFN-γ production by both mouse sple-
nocytes (Fig. 1b and c) and purified T-cells (Fig. 2b and c).
In addition, the inhibitory effect of nPA was reproducible
in the form of BSA-conjugate which imitates the plasma
form (Fig. 1e). These findings suggest that nPA is a prom-
ising research target not only as a risk factor for Refsum
disease but also as a bioactive food component with im-
munomodulatory effects.
IFN-γ is the only member of the type II interferons and
is well known to be secreted by T-cells as well as by
natural killer cells [20]. IFN-γ binds to its ubiquitous re-
ceptor on almost all cell types, and consequently IFN-γ
signaling provides pleiotropic functions and plays a central
role in orchestrating the immune system [21]. In adaptive
immunity, IFN-γ production has been considered the hall-
mark of differentiation of CD4 positive-T-cells into Th1
lineages. T-bet is found in Th1 but not Th2 cells, and is
the key transcription factor regulating the development
and function of IFN-γ-producing Th1 cells [22]. Our
present results showed that the inhibitory effects of nPA
on in vitro IFN-γ production were accompanied by de-
creased levels of T-bet expression (Fig. 1d), implying that
nPA could interfere with Th1 cell differentiation. Although
IFN-γ is a pivotal cytokine for immunity against bacterial
and viral infections, its overexpression and the Th1/Th2
imbalance can lead to the development of IFN-γ-related
autoimmune diseases such as multiple sclerosis, inflam-






Fig. 1 Effects of naturally occurring phytanic acid (nPA) on interferon (IFN)-γ production and T-bet expression in mouse splenocytes. aMouse splenocytes were
incubated with palmitic acid or nPA, followed by an Alamar blue assay to determine cell viability. After incubation of phytohaemagglutinin (PHA)-stimulated
splenocytes with palmitic acid or nPA, the concentrations of IFN-γ in culture supernatants (b), and mRNA expression of IFN-γ (c) and T-bet (d) were measured
by ELISA and qRT-PCR, respectively. e Expression of IFN-γmRNA was determined after PHA-stimulated splenocytes were incubated with nPA-bovine serum
albumin (BSA) conjugate. The data represent means ± SEM. *P<0.05, ** P<0.01 and ***P<0.001 compared to DMSO (dimethyl sulfoxide) control
Nakanishi et al. Lipids in Health and Disease  (2018) 17:147 Page 5 of 8
findings demonstrate the inhibitory effects of nPA on in
vitro IFN-γ production and T-bet expression and suggest
that nPA has the potential to attenuate the symptoms of
these autoimmune diseases.
Both PA and its metabolite pristanic acid were reported
to be natural ligands and activators of several PPAR iso-
forms, among which PPARα was preferentially activated
by nPA [2, 3]. Several studies have demonstrated that
PPARα agonists have immunomodulatory effects on
T-cells and attenuate the symptoms of autoimmune
encephalomyelitis in mouse models of T-cell-mediated
disorders [24]. Numerous studies have addressed the mo-
lecular mechanism for PPARα-mediated regulation of im-
mune and inflammatory responses, and have found that
PPARα activation interferes with NF-κB activity via inhib-
ition of both translocation into the nucleus and transcrip-
tion initiation [25]. Given that NF-κB is one of the most
important transcription factors controlling immune re-
sponses (including T-cell production of IFN-γ and Th1 cell
differentiation) [26], we hypothesized that nPA elicits in-
hibitory effects on IFN-γ production through modulation
of NF-κB activity. We demonstrated significant inhibitory
effects of nPA on the NF-κB-driven transcriptional activity
in A549 cells (Fig. 3b). In addition, this study showed that
PPARα was required for the inhibitory effects of nPA on
NF-κB activity (Fig. 3c). Our studies also found that nPA
suppressed in vitro mouse splenocyte production not only
of IFN-γ but also of other autoimmunity-associated cyto-
kines such as interleukin-17A (Additional file 1: Figure S1),
whose production also requires NF-κB activation [27].
These findings indicate that interference in the NF-κB path-
way via PPARα activation is a potential mechanism of the
immunomodulatory effects of nPA.
Several researchers have reported variation in the
abundance ratio between 3R, 7R, 11R- and 3S, 7R,
11R-PA in the human body according to race, owing to
their different ratios in foods [28]. For instance, butter
made in New Zealand contains fat with a higher ratio of
the 3R, 7R, 11R-isomer, which may correspond to the
higher abundance of this isomer in New Zealanders [29].
In this study, we used a nPA mixture containing equal
amounts of the 3R, 7R, 11R- and the 3S, 7R, 11R-iso-
mers. Therefore, it cannot be concluded whether one or




Fig. 2 Effects of naturally occurring phytanic acid (nPA) on interferon
(IFN)-γ production in purified T-cells. a Immunomagnetically purified T-cells
were incubated with nPA, followed by an Alamar blue assay to determine
cell viability. After T-cells were incubated with nPA under phorbol
12-myristate 13-acetate (PMA)/ionomycin stimulation, IFN-γ mRNA
expression (b) and concentrations of IFN-γ in culture supernatants
(c) were measured by qRT-PCR and ELISA, respectively. The data
represent means ± SEM. *P < 0.05 and ***P < 0.001 compared to
dimethyl sulfoxide (DMSO) control
Nakanishi et al. Lipids in Health and Disease  (2018) 17:147 Page 6 of 8
effects. Furthermore, because our present study focused
on T-cell production of IFN-γ, the effects of nPA on
other types of cells and cytokines have not been deter-
mined. Although impaired NF-κB activity is a possible
mechanism of the immunomodulatory effects of nPA, it
is unknown whether nPA affects the activity of other
transcription factors such as NFAT, AP-1 and STAT
family members, which also play important roles in im-
mune cell functions. In this study, the immunomodula-
tory effects of nPA were investigated only in cell-based
experiments, and the in vivo effects of nPA have not yet
been directly addressed, due to the prohibitively high
cost of nPA. The use of cell-based assays, by ourselves
and other groups [9, 30], has provided useful insight into
the beneficial effects of PA on human health. Further
studies are needed to determine the overall effects of
nPA on immune responses and to elucidate whether the
in vitro immunomodulatory effect of nPA can be repro-
duced under in vivo physiological conditions.
Conclusions
In conclusion, the present study demonstrates that nPA
inhibits in vitro T-cell production of IFN-γ and that
interference in the NF-κB pathway via PPARα activation
is a possible mechanism of the immunomodulatory
effects of nPA. These findings suggest that nPA is a
functional and bioactive fatty acid, and has the potential
for amelioration of T-cell mediated autoimmune disease.
Additional file
Additional file 1: Figure S1. Effects of nPA on interleukin-17A production
in mouse splenocytes. (DOCX 30 kb)
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Fig. 3 Effects of naturally occurring phytanic acid (nPA) on NF-κB activity
in A549 cells. a A549 cells with stable expression of an NF-κB-dependent
luciferase reporter gene, were incubated with palmitic acid or nPA,
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activated receptor α (PPARα). The data represent means ± SEM. **P < 0.01
and ***P< 0.001 compared to dimethyl sulfoxide (DMSO) control
Nakanishi et al. Lipids in Health and Disease  (2018) 17:147 Page 7 of 8
Authors’ contributions
TN designed and performed experiments, analyzed data and drafted the
manuscript. IM, MA, RS and YY performed experiments and analyzed the
data. LE designed experiments and revised the manuscript critically for
important intellectual content. NE, KS and YM designed experiments and
drafted the manuscript. SK designed experiments and wrote the manuscript.
All authors read and approved the final manuscript.
Ethics approval and consent to participate
All experimental protocols were approved by the University of Miyazaki
(approval number: 2014-002).
Competing interests
The authors declare that there is no competing interest associated with this
study.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Biochemistry and Applied Biosciences, Faculty of Agriculture,
University of Miyazaki, 1-1 Gakuenkibanadai-nishi, Miyazaki 889-2192, Japan.
2Department of Applied Chemistry, Faculty of Engineering, University of
Miyazaki, 1-1 Gakuenkibanadai-nishi, Miyazaki 889-2192, Japan. 3Department
of Biology, Harold Washington City College of Chicago, 30 E. Lake St,
Chicago, IL 60601, USA. 4Department of Health Sciences, Blitstein Institute of
Hebrew Theological College, 2606 W. Touhy Ave, Chicago, IL 60645, USA.
Received: 27 December 2017 Accepted: 30 May 2018
References
1. Brown PJ, Mei G, Gibberd FB, Burston D, Mayne PD, McClinchy JE, et al. Diet
and Refsum's disease. The determination of phytanic acid and phytol in
certain foods and the application of this knowledge to the choice of
suitable convenience foods for patients with Refsum's disease. J Hum Nutr
Diet. 1993;6:295–305.
2. Heim M, Johnson J, Boess F, Bendik I, Weber P, Hunziker W, et al.
Phytanic acid, a natural peroxisome proliferator-activated receptor
(PPAR) agonist, regulates glucose metabolism in rat primary
hepatocytes. FASEB J. 2002;16:718–20.
3. Zomer AW, van Der Burg B, Jansen GA, Wanders RJ, Poll-The BT, van Der
Saag PT. Pristanic acid and phytanic acid: naturally occurring ligands for the
nuclear receptor peroxisome proliferator-activated receptor alpha. J Lipid
Res. 2000;41:1801–7.
4. Chen YC, Kao TH, Tseng CY, Chang WT, Hsu CL. Methanolic extract of black
garlic ameliorates diet-induced obesity via regulating adipogenesis,
adipokine biosynthesis, and lipolysis. J Funct Foods. 2014;9:98–108.
5. Hsu WH, Liao TH, Lee BH, Hsu YW, Pan TM. Ankaflavin regulates adipocyte
function and attenuates hyperglycemia caused by high-fat diet via PPAR-γ
activation. J Funct Foods. 2013;5:124–32.
6. Choi JM, Bothwell AL. The nuclear receptor PPARs as important regulators
of T-cell functions and autoimmune diseases. Mol Cells. 2012;33:217–22.
7. Che BN, Oksbjerg N, Hellgren LI, Nielsen JH, Young JF. Phytanic acid
stimulates glucose uptake in a model of skeletal muscles, the primary
porcine myotubes. Lipids Health Dis. 2013;12:14.
8. Nakanishi T, Anraku M, Suzuki R, Kono T, Erickson L, Kawahara K. Novel
immunomodulatory effects of phytanic acid and its related substances in
mice. J Funct Foods. 2016;21:283–9.
9. Roca-Saavedra P, Marino-Lorenzo P, Miranda JM, Porto-Arias JJ, Lamas A,
Vazquez BI, et al. Phytanic acid consumption and human health, risks,
benefits and future trends: a review. Food Chem. 2017;221:237–47.
10. Verhoeven NM, Jakobs C. Human metabolism of phytanic acid and pristanic
acid. Prog Lipid Res. 2001;40:453–66.
11. O'Shea M, Bassaganya-Riera J, Mohede IC. Immunomodulatory properties of
conjugated linoleic acid. Am J Clin Nutr. 2004;79:1199s–206s.
12. Patton S, Benson AA. Synthesis of phytanic acid. J Lipid Res. 1966;7:452–3.
13. Sita LR. Convenient highly stereoselective syntheses of (3R,7R,11R)- and
(3S,7R,11R)-3,7,11,15-tetramethylhexadecanoic acid (phytanic acid) and
the corresponding 3,7,11,15-tetramethylhexadecan-1-ols. J Org Chem.
1993;58:5285–7.
14. Burns CJ, Field LD, Hashimoto K, Ridley DD, Petteys BJ, Rose M. Synthesis of
stereoisomerically pure monoether lipids. Aust J Chem. 1999;52:387–94.
15. Prashad M, Lu Y, Kim HY, Hu B, Repic O, Blacklock T. An improved and
practical Sharpless oxidation of primary alcohols to the carboxylic acids.
Synth Commun. 1999;29:2937–42.
16. Van Harken DR, Dixon CW, Heimberg M. Hepatic lipid metabolism in
experimental diabetes. V. The effect of concentration of oleate on
metabolism of triglycerides and on ketogenesis. J Biol Chem. 1969;
244:2278–85.
17. Wierzbicki AS. Peroxisomal disorders affecting phytanic acid alpha-oxidation:
a review. Biochem Soc Trans. 2007;35:881–6.
18. Jansen GA, Ofman R, Ferdinandusse S, Iilst L, Muijsers AO, Skjeldal OH, et al.
Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase
gene. Nat Genet. 1997;17:190–3.
19. Dhaunsi GS, Alsaeid M, Akhtar S. Phytanic acid activates NADPH oxidase
through transactivation of epidermal growth factor receptor in vascular
smooth muscle cells. Lipids Health Dis. 2016;15:105.
20. Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine
Growth Factor Rev. 2009;20:97–113.
21. Arellano G, Ottum PA, Reyes LI, Burgos PI, Naves R. Stage-specific role of
interferon-gamma in experimental autoimmune encephalomyelitis and
multiple sclerosis. Front Immunol. 2015;6:492.
22. Szabo SJ, Sullivan BM, Stemmann C, Satoskar AR, Sleckman BP, Glimcher LH.
Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma
production in CD4 and CD8 T cells. Science. 2002;295:338–42.
23. Hu X, Ivashkiv LB. Cross-regulation of signaling pathways by interferon-
gamma: implications for immune responses and autoimmune diseases.
Immunity. 2009;31:539–50.
24. Yang Y, Gocke AR, Lovett-Racke A, Drew PD, Racke MK. PPAR alpha
regulation of the immune response and autoimmune encephalomyelitis.
PPAR Res. 2008;2008:546753.
25. Zambon A, Gervois P, Pauletto P, Fruchart JC, Staels B. Modulation of
hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha
activators: clinical and experimental evidence. Arterioscler Thromb Vasc Biol.
2006;26:977–86.
26. Corn RA, Aronica MA, Zhang F, Tong Y, Stanley SA, Kim SR, et al. T cell-
intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-
gamma production and clonal expansion in a Th1 response. J Immunol.
2003;171:1816–24.
27. Cho ML, Kang JW, Moon YM, Nam HJ, Jhun JY, Heo SB, et al. STAT3 and NF-
kappaB signal pathway is required for IL-23-mediated IL-17 production in
spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice.
J Immunol. 2006;176:5652–61.
28. Schröder M, Vetter WGC. EI-MS determination of the diastereomer distribution
of phytanic acid in food samples. J Am Oil Chem Soc. 2011;88:341–9.
29. Eldjarn L, Try K. Different ratios of the LDD and DDD diastereoisomers of
phytanic acid in patients with Refsum’s disease. Biochim Biophys Acta. 1968;
164:94–100.
30. Hellgren LI. Phytanic acid-an overlooked bioactive fatty acid in dairy fat?
Ann N Y Acad Sci. 2010;1190:42–9.
Nakanishi et al. Lipids in Health and Disease  (2018) 17:147 Page 8 of 8
